Assessment of the Knowledge of Retinopathy of Prematurity (ROP) in a Cohort of Nurses in Ogun State, Nigeria


  • OT Bodunde
  • TO Otulana
  • VO Fakolujo
  • OB Ogunfowora



Background: Retinopathy of prematurity (ROP) is a major cause of childhood blindness that can be prevented by early detection and treatment. Nurses and midwives are important stakeholders in neonatal services who can help increase awareness to ensure early detection, thereby reducing the risk of blindness.

Objectives: To determine the knowledge of a cohort of nurses in Ogun state about ROP and ROP screening.

Methods: A cross-sectional study was conducted among nurses and midwives in Ogun State, Nigeria. A self-administered structured Google form (questionnaire) was used to obtain information on their knowledge and practice concerning ROP in their centres.

Results: A total of 117 nurses participated in the study. These comprised 93.2% females, and the mean age was 38.5±3.5years. The majority of the participants were within the 41-50 years age group. A total of 70.9% had ever worked in a neonatal unit. Ninety-seven (82.9%) were aware of ROP, of which 76.1% could correctly define the condition. Sixty-nine per cent had a good knowledge score for ROP, while there was a poor knowledge score for screening in 62.4%.

Conclusion:  Though the participants had good knowledge about ROP, their knowledge of screening for early detection was poor. There is a need for intense dissemination of information on ROP, especially the need for screening of newborn infants among nurses and midwives.


Mamta C, Janardan S, Nisha D, Meghna S, Harish D. Incidence and Prevalence of Retinopathy of Prematurity in a Tertiary Care Centre of North India. Maedica (Bucur).2023;18:232-237.

Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Preliminary report. Am J Ophthalmol. 2018; xxviii.

Fevereiro-Martins M. Marques-Nerves C, Guimaraes H, Bicho M. Retinopathy of prematurity: a review of pathophysiology and signalling pathways. Surv Ophthalmol 2023;68:175-210 :11.007

Bishnol K, Prasad R, Upadhyyay T, Mathurkar S. A Narrative Review on Managing Retinopathy of Prematurity: Insights Into Pathogenesis, Screening, and Treatment Strategies. Cureus. 2024;16:e56168.

Hong EH, Sin YU, Cho H. Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clin Exp Pediatr 2022;65:115-126.

Darlow BA, Gilbert C. Retinopathy of prematurity- a world update. Semin Perinatol 2019;43:315-316.

Rybus-Kalinowska B, Kwiatkowski S, Chojnacka K, Jochem J. Retinopathy of prematurity-etiopathogenesis and treatment. Pediatr Med Rodz 2017;13:22-28.

Keran Q, Tinley C, Horn A, Pollock T, Steffen J, Joolay Y. Retinopathy of prematurity in a cohort of neonates at Groote Schuur Hospital Cape Town, South Africa. S Afr Med J 2016;107:64-69. 2016.v107.i1.11226

Seobi T, Maposa I, Makgotioe MA. Retinopathy of Prematurity screening in Johannesburg, South Africa: A comparative study. Afr Vision Eye Health 2022;81:a771.

Ademola-Popoola DS, Fajolu I, Gilbert C, Olusanya B, Onakpoya O, Ezisi C et al. Strengthening retinopathy of prematurity screening and treatment services in Nigeria: a case study of activities, challenges and outcomes 2017-2020. BMJ Open Ophthalmol 2021;6.

Fajolu IB, Rotimi-Samuel A, Aribaba OT, Musa KO, Akinsola FB, Ezeaka VC, Onakoya AO. Retinopathy of Prematurity and associated factors in Lagos, Nigeria. Paediatr Int Child Health 2015;35:324-328.

Ezeanosike OB, Ezeanosike E, Akamike IC, Okedo-Alex IN. Prevalence and risk factors of retinopathy of prematurity in Africa: A systematic review and meta-analysis. Niger J Paediatr 2021;48:114-127.

Adio AO, Ugwu RO, Nwokocha CG, Eneh AU. Retinopathy of Prematurity in Port Harcourt, Nigeria. ISRN Ophthalmol. 2014;481527:1-6.

Braimah IZ, Enweronu-Laryea C, Sackey AH, Kenu E, Agyabeng K, Ofori-Adjei ID, et al. Incidence and risk factors of retinopathy of prematurity in Korle-Bu Teaching Hospital: a baseline prospective study 2020. BMJ Open 2020;10: e035341.

Al-Balawi HB, Al-Balawi NS, Al-Suhaimi NA, Al-Balawi AA, Al-Atawi AS, Mirghani HO, et al. Incidence and Risk Factors for Retinopathy of Prematurity in Tabuk City, KSA. Middle East Afr J Ophthalmol 2020;27:105-109.

Sathiamohanraj SR, Shah PK, Senthilkumar D, Narendran V, Kalpana N. Awareness of retinopathy of prematurity among pediatricians in a tier two city of South India. Oman J Ophthalmol 2011;4:77-80.

Sankar KB, Pappa P. A study to assess the knowledge regarding retinopathy of prematurity among staff nurses in a tertiary care centre in Kerala. Int J Nurs Educ Res 2018;6:253.

Wang SD, Zhang GM, Shenzhen. Screening for Retinopathy of Prematurity Cooperative Group. Laser therapy versus intravitreal injection of anti-VEGF agents in monotherapy of ROP, a meta-analysis. Int J Ophthalmol 2020;13:806-815.

Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for the treatment of retinopathy of prematurity; Cochrane Database Syst Rev 2018;1:CD 009734.

Zhang GM, Yang MM, Zeng J, Vakros G, Su KJ,Chen MH, et al. Screening for Retinopathy of Prematurity Cooperative Group. Comparison of intravitreal injection of ranibizumab versus laser therapy for zone II treatment-requiring retinopathy of prematurity. Retina 2017;37:710-717.

Thuileiphy T, Joshi P, Dolma Y, Paul J, Joshi M, Gudiya, et al. A descriptive survey on knowledge gap related to retinopathy of prematurity and its prevention and management among nurses in a tertiary care hospital. Indian J Ophthalmol.2021;69:2122-2125.

Bambamba J, Fresno C, Bambamba A, Chiyinde S, Fumo M, Tomo H, et al. Awareness about retinopathy of prematurity among nurses working at neonatal intensive care unit of Nampula Central Hospital in Mozambique, 2021. Adv Ophthalmol Vis Syst 2022;12:14‒17.






Original Research